Company Filing History:

7 out of 1,970

Amgen Inc.

patents

3 out of 1,535

Boehringer Ingelheim International Gmbh

patents

1 out of 1

Boehringer Ingleheim Gmbh

patent

4. 1 out of 832,680

Other

patents

Years Active: 1997-2007

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7282483 - Method of ameliorating the harmful effects of TNF using a polypeptide having the ability to bind to TNF (2007-10-16),

2. 7264944 - TNF receptors, TNF binding proteins and DNAs coding for them (2007-09-04),

3. 7238776 - TNF binding proteins (2007-07-03),

4. 6440693 - TNF receptors, TNF binding proteins and DNAS coding for them (2002-08-27),

5. 6417158 - Method of ameliorating the harmful effects of TNF using a polypeptide having the ability to bind to TNF (2002-07-09),

6. 6294352 - TNF receptors, TNF binding proteins and DNAs coding for them (2001-09-25),

7. 6271346 - TNF Receptors, TNF binding proteins and DNAs coding for them (2001-08-07),

8. 6221675 - TNF receptors, TNF binding proteins and DNAs coding for them (2001-04-24),

9. 5854004 - Process for screening substances capable of modulating a (1998-12-29),

10. 5798228 - Recombinant production of dog and horse type I interferons (1998-08-25),

11. 5605688 - Recombinant dog and horse type I interferons (1997-02-25),

12. 5602010 - DNA encoding equine-gamma interferon and recombinant production of (1997-02-11),

Title: Biography of Inventor Adolf Himmler

Introduction: Adolf Himmler is a notable inventor based in Vienna, Austria. He holds a total of 12 patents, showcasing his significant contributions to the field of biotechnology. His work primarily focuses on the development of methods to ameliorate the harmful effects of tumor necrosis factor (TNF).

Latest Patents: His latest patents include a method of ameliorating the harmful effects of TNF using a polypeptide that binds to TNF. This invention provides DNA sequences coding for a TNF-binding protein and the TNF receptor, which can be utilized in pharmaceutical preparations to treat conditions where TNF has detrimental effects. The recombinant TNF-binding protein is essential for investigating substances that interact with the TNF receptor and their effects on TNF's biological activity.

Career Highlights: Throughout his career, Himmler has worked with prominent companies such as Amgen Inc. and Boehringer Ingelheim International GmbH. His experience in these organizations has contributed to his expertise in the field of biotechnology and patent development.

Collaborations: Himmler has collaborated with notable coworkers, including Rudolf Hauptmann and Christian Stratowa. These partnerships have further enhanced his research and innovation capabilities.

Conclusion: Adolf Himmler is a distinguished inventor whose work has made a significant impact in the biotechnology sector. His innovative patents and collaborations reflect his dedication to advancing medical

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.